Prescription for Change 2025
Page 23 of 28 · WEF_Prescription_for_Change_2025.pdf
Contributors
Acknowledgements
Irene Aninye
Society for Women’s Health Research
Diego Baptista
Wellcome Trust
Kihara Anne Beatrice
The International Federation of Gynecology
and Obstetrics (FIGO)
Catharina Boehme
World Health Organization
Nicholas Brooke
The Synergist
Alejandra Cardenas
Center for Reproductive Rights
Alison Cave
Medicine and Healthcare products Regulatory
Agency (MHRA) UK
Anna Coates
World Health Organization
Alysha Croker
Health Canada
Corinne de Vries
European Medicines AgencyVictoria DiBiaso
Sanofi
Hema Divakar
The International Federation of Gynecology
and Obstetrics (FIGO)
Victor Dzau
National Academy of Medicine
Christine Enciso
Regeneron
Marwan Fathallah
Drug Information Association (DIA)
Elizabeth Garner
Women’s Health Access Matters
Josette Gbemudu
MSD
Maya Goldstein
Impact Global Health
Christine Haenggeli
Swiss Medic
Shirin Heidari
Gender, Evidence, and Health Network (GENDRO)World Economic Forum
Shyam Bishen
Head, Centre for Health and Healthcare;
Member of the Executive Committee
Anna Bode
Project Fellow, Women’s Health
Emily Fitzgerald
Initiatives Lead, Women’s Health
Amira Ghouaibi
Head, Global Alliance for Women’s HealthThe Gates Foundation
Sanjana Bhardwaj
Deputy Director, Program Advocacy
and Communications
Kaitlin Christenson
Senior Program Manager, Program Advocacy
and Communications
Kearney
Paula Bellostas Muguerza
Senior Partner, Global Lead, Healthcare
and Life Sciences
Science and Innovation Working GroupThis seminal work is a result of the collective expertise and invaluable contributions of the distinguished
experts in the working groups, whose insights have been fundamental to its development.
Prescription for Change: Policy Recommendations for Women’s Health Research
23
Ask AI what this page says about a topic: